Michael David Smith Kal Vista Pharmaceuticals, Inc. (KALV) insider trading activity

KALV Quotes by TradingView

Michael David Smith is Senior VP, Development of KalVista Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of KALV, which is worth approximately $0. The most recent transaction as insider was on Jun 01, 2021, when has been sold 7,500 shares (Common Stock) at a price of $26.83 per share, resulting in proceeds of $201,225. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Michael David Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 01 2021
SELL
Open market or private sale
$201,225 $26.83 p/Share
7,500 Reduced 100.0%
0 Common Stock
Jun 01 2021
BUY
Exercise of conversion of derivative security
$62,925 $8.39 p/Share
7,500 Added 50.0%
7,500 Common Stock
Apr 28 2021
SELL
Open market or private sale
$257,961 $25.76 p/Share
10,014 Reduced 100.0%
0 Common Stock
Apr 28 2021
BUY
Exercise of conversion of derivative security
$84,017 $8.39 p/Share
10,014 Added 50.0%
10,014 Common Stock
MDS

Michael David Smith

Senior VP, Development
Cambridge, MA

Track Institutional and Insider Activities on KALV

Follow KalVista Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALV shares.

Notify only if

Insider Trading

Get notified when an Kal Vista Pharmaceuticals, Inc. insider buys or sells KALV shares.

Notify only if

News

Receive news related to KalVista Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KALV